쓰리빌리언
6,200KRWMarket close of 10/28 (Wed)
Up +11.11%+620KRWMarket close of 10/28 (Wed)
- Open
- 5,610
- High
- 6,210
- Low
- 5,590
- Day range
- Day range low 5,590 high 6,210, open 5,610, close 6,200, previous close 5,580
- Volume
- 111×10K shares
- 6.7B KRW 1.31× the 20-session average
Market close of 10/28 (Wed)
Where it sits in the 1-year range
15%1-year close range 4,060 to 18,800 won, 15% up from the low
15% of the way up from the lowest close in 1 year (252 sessions) · -67.0% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/28 (Wed)
Market close data of 2026-10-28Points to check
- Daily moveto check+11.11%+11.11%, 2.0× the usual (20-session average ±5.44%)That day +11.11% · usual ±5.44% · large-move threshold ±10.9%
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
The other 2
- Foreign & institutionalnot verified
- Trading value1.3×usual range
See the full check report
Quarterly results · Q2 2026
- Revenue3.8B KRW
- vs. year ago
- —
- vs. prior quarter
- +12.8%
- Operating income-1.7B KRW
- vs. year ago
- —
- vs. prior quarter
- Still a loss
- Operating margin-43.9%
- vs. year ago
- —
- vs. prior quarter
- +5.5 pp
Quarterly operating income trend
As of the latest official close · 2026-10-28Valuation filing date · 2026-08-13Same sector · 바이오 R&D
Up +1.90%· 40 of 64 stocks up, preferred shares excluded · trading value 209.6B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -12.0% | Up +2.06% | 52.9B KRW |
| 디앤디파마텍 | Close over the last 20 sessions +2.3% | Up +5.15% | 28.1B KRW |
| 올릭스 | Close over the last 20 sessions -5.4% | Up +7.40% | 22.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -16.7% | Up +3.60% | 13.4B KRW |
| 프로티나 | Close over the last 20 sessions -3.9% | Up +5.21% | 10.3B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 18 days
- Next data 10/30 (Fri) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.